The purpose of this work is to estimate the prevalence of hypertension in the urban population of Mexico. We studied a multistage national sample representative of the urban population in 417 cities of over 2500 people. The blood pressure of 14 657 individuals (6053 men and 8604 women) aged 20-69 years was measured after a 5-min rest using a standard mercury sphygmomanometer. The survey personnel had been previously trained and standardised.
Introduction
Urbanization and aging are the principal changes that have affected the demographic features of Mexico in the present century. The percentage of the population living in localities with more than 2500 people increased from 29% to 71% between 1910 and 1990, and this urban sector is now concentrated in less than 1600 localities (Ͻ2% of the total localities). Family-planning programmes and a general improvement in public health have substantially modified the age composition of the population. Between 1970 and 1990 the percentage of people aged 10 years or over increased from 67.1% to 74.5%. These trends have contributed to major shifts in Mexican epidemiology: communicable diseases now play a less important role in morbidity and mortality than cardiovascular diseases and other degenerative pathologies.* In 1992-1993 the Mexican Ministry of Health conducted a National Survey of Chronic Diseases (NSCD) in the urban population. The overall goal was to estimate the prevalence of non-insulin dependent diabetes mellitus, renal pathology, coronary heart disease, dislipidaemia and hyperten-with age. In individuals under 50 years of age, women had lower rates than men, but the difference disappeared in the older groups. The awareness of hypertension (28%) as well as the success of treatment (22%) were low in our sample. Our results had more similarities than differences with respect to those observed in other national surveys.
It is concluded that hypertension in Mexico is an important public health problem similar to that seen in developing and developed nations. Efforts should be aimed at strengthening measures to prevent and control hypertension in Mexico. More information is needed of the sort obtained from longitudinal studies.
sion. Hypertension has been identified as a major risk factor for cardiovascular mortality. 1 We present here data on the prevalence of hypertension, and on awareness, medication and control of hypertension.
Materials and methods
A multistage nationwide sampling procedure was used. Mexico is a Republic composed of 31 States and a Federal District housing the capital, Mexico City. For the purpose of the survey, the country was divided into three regions. The North, the Centre and the South were allotted 10 States each, five of which were randomly selected for inclusion in the survey. A fourth region was the Metropolitan area comprising Mexico City and 10 adjacent counties of the State of Mexico. These regions differ in industrialization and mortality indicators.
A random sample of BGSU (Basic Geographical Statistical Units) was obtained in the selected States * All the demographic data in this document were obtained from four publications: (1) and the Federal District from a database periodically updated by the Instituto Nacional de Geografía y Estadística (National Institute of Geography and Statistics). Only towns with more than 2500 people were taken into consideration. A random selection of neighbourhood blocks was carried out and all adults (20-69 years of age) in all households of these blocks were surveyed with the exception of those living in military, religious, health and other institutions. A total of 417 towns were studied. This number was estimated to be sufficiently representative of the Mexican urban population which, according to the 1990 National Census, constitutes 71% of the total population.
A target of 4730 individuals and 2030 households per region was estimated using the household as the sampling unit and working on the basis of 2.33 adults per household as indicated in the 1990 Mexican Census. The size of the sample was considered big enough to detect risk factors with a prevalence of at least 4%.
Fieldwork
The survey was carried out between September 1992 and August 1993. It was done sequentially starting in the Metropolitan area, continuing in the Centre and the North and ending up in the South. A single team of 30 nurses and social workers performed the survey in the four regions. The members of the team were previously trained and standardised: they were required to take blood pressure and to make anthropometric measurements until they coincided with the measurements taken by experts from the Mexican National Institutes of Health. The training and pilot survey lasted 28 weeks and included six trial runs carried out under the surveillance of experts in which a total of 200 households were visited in a locality near Mexico City (Milpa Alta).
A questionnaire was administered to every available adult living in the selected households with the aim of collecting data on family history, clinical symptoms and therapy related to arterial hypertension, diabetes, myocardial infarction, strokes, renal insufficiency, limb amputation, and ophthalmologic surgery. Information was collected on risk factors such as smoking, alcohol consumption and consanguinity, as well as data on the reproductive history of the women. In addition, a household questionnaire gathered information on family structure, housing facilities and sociodemographic characteristics.
The blood pressure of the participants was measured manually by trained observers using standard mercury sphygmomanometers (ADEX, Model M1-300). An appropriate sized cuff (regular, large or thigh) was placed on the participant's right arm. With the subject in the sitting position, after having emptied their bladder and rested for 5 min, the cuff was inflated and the pulse obliteration measured. The I and V Korotkoff phases were used as criteria for determining the systolic and diastolic blood pressure (SBP and DBP respectively). The participants were classified according to the criteria of the Joint National Committee for Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). 2 They were considered hypertensive if DBP was Ͼ90 mm Hg and/or SBP Ͼ140 mm Hg, or if the subject reported treatment with antihypertensive medication (see below). The criteria for stages of abnormality for DBP were: Stage I, 90-99; Stage II, 100-109; Stage III, Ͼ110 mm Hg, and for SBP: Stage I, 140-159; Stage II, 160-179; Stage III, Ͼ180 mm Hg. The same questionnaire was applied to each of the participants individually. It was made up of a series of structured questions aimed at discovering whether blood pressure had been measured previously, and to what extent the individual was aware of his blood pressure status. In the individuals previously diagnosed as hypertensive, the questionnaire explored whether the patient was taking antihypertensive drugs; if this was the case, he or she was asked to show the prescribed drug to the interviewer. The control of hypertension was considered good when the patient was taking antihypertensive medication and had normal DBP and SBP.
Data analysis
The information was typed into a database on a PC computer using range and logic checks to detect erroneous information. The data were analysed using gaussian and non-gaussian statistical methods that included chi-square analysis, regression analysis. Out of the 18 036 individuals targeted by the survey, 14 657 provided complete information (3727, 3907, 3634 and 3389 subjects from the North, Centre, South and Metropolitan areas, respectively). This non-response rate of 19% (3379/18 036) was higher in the Metropolitan area (28%) than in the other three regions (14 -16%). The final sample had a male: female ratio of 1:1.4, which contrasts with the 1:1.1 of the 1990 Mexican Census and was due to the unavailability of men who had temporarily migrated or were not in any of the two or three visits that were made. The fewer number of men answering the questionnaire did not appear to affect our sampling to a great extent as there were no major deviations in the age distribution of our sample as compared to the 1990 National Census as shown in Table 1 . Table 2 shows the crude prevalence of hypertension in relation to age and gender and the age-adjusted data in relation to gender. The crude prevalence of hypertension was 28.1% in women and 37.5% in men and increased with age in both genders. Young men had a clearly higher prevalence than young women but the difference practically disappeared when both groups reached 50 years of age as shown by the chi-square analysis in Table 2 . These gender differences can be seen more clearly in Table 3 which shows a simple linear regression analysis of the crude data of Table 2 . The women had significantly lower hypertension prevalence at age 20 but as a consequence of their significantly larger slope, they caught up with men at age 64.
Results
In regard to the degree of hypertension, Stage I hypertension was lower in women (n = 1215, 15%) than men (n = 1203, 20%). Stages II and III were similar in men and women and showed similar increments with age: they were pooled and considered as severe hypertension. Table 4 shows the proportion of severe hypertension in the untreated hypertensives as a function of age and gender. Overall, severe hypertension increased from 38% in the first two age groups to a new plateau of 43-47% upon reaching 40 years of age. This increase was present in both men and women. Table 5 shows the distribution of isolated and combined DBP and SBP. The information on women and men was similar so that only global data is shown in Table 5 . The proportion of individuals with the combined abnormalities increased upon reaching 40 years of age (49-50% in young adults vs 61-63% in older subjects). Also, the isolated SBP abnormality increased but only in the 60-69 age group. These increases resulted in a decrease in isolated DBP, which dropped at 40+ years of age and again in the 60-69 age group.
The mean values of SBP and DBP in the 501-treated hypertensives were similar to those in the 4193 untreated hypertensives in both men and women (data not shown) which suggests a poor pharmacological control of hypertension. Table 6 shows that there was a general low awareness of hypertension, lower in men than women, ie, only 7% of the men vs 15% of the women knew they were hypertensive, and the gender difference of awareness of hypertension was present in all age groups (data not shown). In those aware of their disease a similar percentage of both genders (38%) underwent treatment but women were clearly superior to men in awareness, treatment and success of treatment (Table 6 ). In spite of the better performance of the women, the global figures of 'awareness' (28%) and 'success of treatment' (22%) were dismally low.
Discussion
We consider that our study provides a fairly accurate estimation of the prevalence of hypertension in the adult urban population of Mexico in the early 1990s. Our sample was basically urban, ie, 86% of our cases lived in cities with more than 15 000 people and only 14% could be considered as semiurban, living in communities between 2500 and 15 000 people. The main result was an overall crude prevalence of hypertension of 28.1% in women and 37.5% in men (27.2% and 37.1% age adjusted). Both men and women showed a trend of increasing hypertension with age varying in the age period of 20 to 69 from 13.5% to 63.5% in women and from 25.6% to 64.0% in men (Table 2 ). More than half of our treated hypertensives (2418/4193 = 58%) had Stage I hypertension, including the older age brackets, although there was a small increase of more severe hypertension upon reaching 40 years of age. Also at this age there was an increase in combined DBP+SBP hypertension at the expense of isolated DBP hypertension, and a further decrease of isolated DBP hypertension with an increase in isolated SDP in the age bracket 60-69 years. In spite of the crosssectional nature of our study, this behaviour could mean, among other things, that high DBP might be a worse prognosis than high SBP. A plateau and even a decrease in the prevalence of DBP hypertension with increasing age has been observed by Kannel 3 and has been attributed to a possible exhaustion of susceptible individuals as discussed by Silagy and McNeil. 4 We included in Table 5 the data on stages and types of hypertension as a function of age since it may be useful for the interpretation of future cross-sectional studies (see below).
We were unable to detect regional differences in the prevalence of hypertension, ie, we expected a higher rate in the Metropolitan area (with nearly 20 million inhabitants) but it was similar to those of the Northern and Southern regions with more sedate lifestyles. One possible explanation is that lifestyle factors influencing the prevalence of hypertension did not vary much in the urban environments sampled by us. As an example, an associated risk factor for hypertension such as overweight, especially in women, showed a similarly high prevalence in the four regions sampled in our survey. 5 We are in the process of evaluating other variables related to hypertension in our sample, for example, smoking and socioeconomic indicators.
A comparison of our crude data with that of national surveys of hypertension performed on [1988] [1989] [1990] [1991] . The latter suggests that our high prevalence of hypertension is not due to genetic peculiarities alone. On the other hand, there were several methodological differences between these studies and ours. We used a single blood pressure measurement (which would tend to increase our prevalence 10 ), while the Paraguayan survey used the second measurement and the others the average from two to four measurements. Another cause of increased values in our study would be that our sample only included urban population whereas the others included rural-dwellers who have less hypertension than city-dwellers, at least in China. 11 On the other hand, Paraguayans are falsely lower as they exclude hypertensives under treatment in their analysis, whereas the Egyptians perhaps increased theirs as they were the only ones with no age limit (versus 69 years in our study and 74 years in Paraguayans and Mexican-Americans). In the final analysis, these methodological differences could well even out, but we think that in spite of them, the four studies show important similarities and disparities in the prevalence of hypertension. The similarities were: (1) high prevalence in adults; (2) hypertension increases with age; and (3) it is lower in young women than young men. The disparities were: (1) the highest increments with age occur in Mexicans and Paraguayans; (2) the lowest prevalence is in Mexican-Americans aged 20 to 39, specially women; (3) Egyptians differ from all others inasmuch as older women (45+ years of age) have a higher prevalence than men of similar age.
A tentative conclusion from the similarities would be that a high prevalence of hypertension is a common occurrence in urban and rural groups in developed and underdeveloped countries. From the disparities, we infer that there are factors modulating the prevalence of hypertension in these countries, some known (ie, overweight, alcohol and tobacco consumption) and others perhaps yet unidentified. Because of this, we believe we need to know more about the occurrence of hypertension in repeated cross-sectional studies, or in longitudinal studies to improve our chances of decreasing its high frequency. For instance, the lower proportion of hypertensive young women than young men and the absence of this gender difference upon reaching 50 years of age in our study, and in others, would suggest a menopausal effect still to be studied longitudinally. The same applies for the possible age associations of overweight and hypertension 12, 13 and for the changes observed in the present study in type and degree of hypertension upon reaching 40 years of age (Table 5 ).
In conclusion, we think our study underlined the fact that hypertension is a public health problem in Mexico and that there was a low awareness and poor control of hypertension as observed in Egypt and Paraguay. 8, 9 This points out the need to improve the prevention, detection and control of hypertension in Mexico and to achieve a better understanding of the mechanisms leading to its occurrence especially through longitudinal studies.
